This course comprises of a single tutorial where we aim to explain the differences between F18 Fluoride and FDG and its uses as they relate to reporting bone metastasis. The intended audience for this course is radiologists and nuclear medicine physicians who intend to train to report F18 Fluoride PET-CT in metastatic bone disease, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT.
It is expected that candidates have prior knowledge of FDG PET-CT imaging before undertaking the tutorials.
